A Phase I/II Study of RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 07 Jul 2017
At a glance
- Drugs RV 001 (Primary)
- Indications Prostate cancer; Solid tumours
- Focus Adverse reactions
- Sponsors RhoVac
- 02 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 26 Jun 2017 Status changed from planning to recruiting.
- 10 Nov 2016 New trial record